Back
GNI Group 10K Form
Buy
74
GNIIF
GNI Group
Last Price:
21.81
Seasonality Move:
-0.75%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive GNIIF News And Ratings
See the #1 stock for the next 7 days that we like better than GNIIF
GNIIF Financial Statistics
Sales & Book Value
| Annual Sales: | $185.39M |
|---|---|
| Cash Flow: | $-7.82M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $4.57 |
| Price / Book: | 4.77 |
Profitability
| EPS (TTM): | 0.98460 |
|---|---|
| Net Income (TTM): | $48.98M |
| Gross Margin: | $159.88M |
| Return on Equity: | 21.02% |
| Return on Assets: | 12.03% |
GNI Group Earnings Forecast
Key GNI Group Financial Ratios
- The Gross Profit Margin over the past 16 years for GNIIF is 86.24%.
- The Selling, General & Administrative Expenses for GNIIF have been equal to 58.79% of Gross Profit Margin.
- The Research & Development expenses have been 9.83% of Revenue.
- The Interest Expense is 15.45% of Operating Income.
- The Net Earning history of GNIIF is 31.12% of Total Revenues.
- Per Share Earnings over the last 16 years have been positive in 7 years.
GNI Group Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | GNIIF |
| Website: | gnipharma.com |
Debt
| Debt-to-Equity Ratio: | 0.15 |
|---|---|
| Current Ratio: | 2.83 |
| Quick Ratio: | 2.42 |
Price-to-Earnings
| Trailing P/E Ratio: | 18.48 |
|---|---|
| Forward P/E Ratio: | 0 |